NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edgewise Therapeutics, Inc. ("Edgewise" or "the Company") (NASDAQ:EWTX). Investors who purchased Edgewise securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EWTX. […]

NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Unicycive Therapeutics, Inc. ("Unicycive" or "the Company") (NASDAQ:UNCY). Investors who purchased Unicycive securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/UNCY.

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The J.M. Smucker Company ("Smucker" or "the Company") (NYSE:SJM). Investors who purchased Smucker securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SJM.

NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nutex Health, Inc. ("Nutex" or "the Company") (NASDAQ:NUTX). Investors who purchased Nutex securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NUTX.

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / If you suffered a loss on your XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (NYSE:XIFR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/xplr-infrastructure-lp-f-k-a-nextera-energy-partners-lp-lawsuit-submission-form?prid=159454&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=159448&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lockheed Martin To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Lockheed Martin between January 23, 2024 and July 21, 2025 and would like to discuss your legal rights, call Faruqi

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Altimmune, Inc. ("Altimmune, Inc.") (NASDAQ:ALT) concerning possible violations of federal securities laws. Altimmune announced topline results from the IMPACT Phase 2b trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH), revealing that the

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fiserv, Inc. ("Fiserv" or the "Company")(NYSE:FI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / If you suffered a loss on your Flywire Corporation (NASDAQ:FLYW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/flywire-corporation-lawsuit-submission-form?prid=159456&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call